Find a Pediatric Clinical Trial

Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our list of clinical trials that are currently enrolling new pediatric patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

Showing 1 - 20 of 76 trials
Titlesort icon Investigator Disease(s)
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with B cell Lymphoid Malignancies
[Protocol 06-066]
Barker, Juliet, MBBS Transplantation
A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Melanoma
[Protocol 10-229]
Young, James, MD Melanoma
A Phase I Study of Clofarabine Plus Topotecan, Vinorelbine, Thiotepa, and Dexamethasone in Pediatric Patients with Relapsed or Refractory Acute Leukemia
[Protocol 07-012]
Steinherz, Peter, MD
Acute Lymphoblastic Leukemia
Acute Myelocytic Leukemia
Acute Myelogenous Leukemia
Leukemia
A Phase I Study of Convection-Enhanced Delivery of 124I-8H9 for Patients with Non-Progressive Diffuse Pontine Gliomas Previously Treated with Radiation Therapy
[Protocol 11-011]
Souweidane, Mark, MD
Brain Cancer
Glioma
A Phase I Study of Donor T Cells Sensitized with Pentadecapeptides of the CMV-PP65 Protein for the Treatment of CMV Infections Following Allogeneic Hematopoietic Stem Cell Transplants
[Protocol 05-065]
O'Reilly, Richard, MD Transplantation
A Phase I Study of Humanized 3F8 Monoclonal Antibody in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 11-009]
Basu, Ellen, MD, PhD Neuroblastoma
A Phase I Study of Intraperitoneal Radioimmunotherapy with 131I-8H9 for Patients with Desmoplastic Small Round Cell Tumors and Other Solid Peritoneal Tumors
[Protocol 09-090]
Modak, Shakeel, MD Peritoneal Cancer
A Phase I Study of Intrathecal Radioimmunotherapy Using 131I-8H9 for Central Nervous System/Leptomeningeal Cancers
[Protocol 03-133]
Kramer, Kim, MD
Brain Cancer
CNS Cancer
Neuroblastoma
A Phase I Study of Ipilimumab in Children, Adolescents, and Young Adults with Treatment-Refractory Cancer
[Protocol 10-193]
Wexler, Leonard, MD
Advanced Cancer
Hodgkin's Disease
Lymphoma
Melanoma
Nephroblastoma
Non-Hodgkin's Lymphoma
Sarcoma
Solid Tumors
A Phase I Study of Modified T Cells Targeted to CD19-Positive Acute Lymphoblastic Leukemia Relapsing After Allogeneic Stem Cell Transplantation
[Protocol 11-038]
Kernan, Nancy, MD
Acute Lymphoblastic Leukemia
Leukemia
A Phase I Study of Panitumumab in Children with Solid Tumors
[Protocol 08-020]
Meyers, Paul, MD Solid Tumors
A Phase I Study of Perifosine with Temsirolimus for Recurrent Pediatric Solid Tumors
[Protocol 09-124]
Dunkel, Ira, MD Solid Tumors
A Phase I Study of Plerixafor as a Chemosensitizing Agent for Children with Relapsed Acute Leukemia or Myelodysplastic Syndromes
[Protocol 11-208]
Trippett, Tanya, MD
Acute Leukemia
Acute Lymphoblastic Leukemia
Acute Myelogenous Leukemia
Leukemia
Myelodysplastic Syndrome
A Phase I Study of Vemurafenib in Adolescents with Inoperable Stage IIIC/IV Melanoma with V600 BRAF Mutations
[Protocol 11-198]
Pratilas, Christine, MD
Advanced Cancer
Melanoma
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
[Protocol 07-055]
O'Reilly, Richard, MD
Leukemia
Myelodysplastic Syndrome
A Phase I Trial of NECTAR: Nelarabine, Etoposide, and Cyclophosphamide in Children with T-Cell Acute Lymphoblastic Leukemia
[Protocol 11-119]
Trippett, Tanya, MD
Acute Leukemia
Acute Lymphoblastic Leukemia
Leukemia
A Phase I/II Clinical Study of Vorinostat Plus Etoposide in Pediatric Patients with Refractory Solid Tumors
[Protocol 10-096]
Trippett, Tanya, MD
Advanced Cancer
Solid Tumors
A Phase I/II Study of Brentuximab (SGN-35) in Pediatric Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma or Hodgkin Lymphoma
[Protocol 11-210]
Trippett, Tanya, MD
Hodgkin's Disease
Lymphoma
Non-Hodgkin's Lymphoma
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders
[Protocol 95-024]
O'Reilly, Richard, MD
Cancer
Leukemia
Lymphoma
Transplantation
A Phase I/II Trial of Clofarabine, Melphalan, and Thiotepa Followed by an Allogeneic Stem Cell Transplant for the Treatment of High-Risk and/or Advanced Hematologic Malignancies
[Protocol 06-125]
Boulad, Farid, MD
Leukemia
Myelodysplastic Syndrome
Transplantation